96 related articles for article (PubMed ID: 16469558)
1. Botulinum toxin and cellular proliferation in the prostate.
Lin VK
J Urol; 2006 Mar; 175(3 Pt 1):817. PubMed ID: 16469558
[No Abstract] [Full Text] [Related]
2. Investigating botulinum toxin A on the functional properties of the prostate.
Choo MS
Eur Urol; 2007 Aug; 52(2):324-5. PubMed ID: 17376584
[No Abstract] [Full Text] [Related]
3. Novel action of botulinum toxin on the stromal and epithelial components of the prostate gland.
Chuang YC; Huang CC; Kang HY; Chiang PH; Demiguel F; Yoshimura N; Chancellor MB
J Urol; 2006 Mar; 175(3 Pt 1):1158-63. PubMed ID: 16469644
[TBL] [Abstract][Full Text] [Related]
4. The application of botulinum toxin in the prostate.
Chuang YC; Chancellor MB
J Urol; 2006 Dec; 176(6 Pt 1):2375-82. PubMed ID: 17085104
[TBL] [Abstract][Full Text] [Related]
5. Effects of purified newly developed botulinum neurotoxin type A in rat prostate.
Nishiyama Y; Yokoyama T; Tomizawa K; Okamura K; Yamamoto Y; Matsui H; Oguma K; Nagai A; Kumon H
Urology; 2009 Aug; 74(2):436-9. PubMed ID: 19371936
[TBL] [Abstract][Full Text] [Related]
6. Effects of botulinum toxin A on the contractile function of dog prostate.
Lin AT; Yang AH; Chen KK
Eur Urol; 2007 Aug; 52(2):582-9. PubMed ID: 17386969
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin type A inhibits the growth of LNCaP human prostate cancer cells in vitro and in vivo.
Karsenty G; Rocha J; Chevalier S; Scarlata E; Andrieu C; Zouanat FZ; Rocchi P; Giusiano S; Elzayat EA; Corcos J
Prostate; 2009 Aug; 69(11):1143-50. PubMed ID: 19399787
[TBL] [Abstract][Full Text] [Related]
8. [Benign prostatic hyperplasia--botulinum toxin A in BPH with small prostate volume].
Adler S
Aktuelle Urol; 2006 Sep; 37(5):315-6; discussion 315-6. PubMed ID: 17004177
[No Abstract] [Full Text] [Related]
9. Intraprostatic botulinum toxin a injection inhibits cyclooxygenase-2 expression and suppresses prostatic pain on capsaicin induced prostatitis model in rat.
Chuang YC; Yoshimura N; Huang CC; Wu M; Chiang PH; Chancellor MB
J Urol; 2008 Aug; 180(2):742-8. PubMed ID: 18554636
[TBL] [Abstract][Full Text] [Related]
10. Perspective of Botox for treatment of male lower urinary tract symptoms.
Ilie CP; Chancellor MB
Curr Opin Urol; 2009 Jan; 19(1):20-5. PubMed ID: 19057212
[TBL] [Abstract][Full Text] [Related]
11. Use of intradermal botulinum toxin to reduce sebum production and facial pore size.
Shah AR
J Drugs Dermatol; 2008 Sep; 7(9):847-50. PubMed ID: 19112798
[TBL] [Abstract][Full Text] [Related]
12. Histologic features in the urinary bladder wall affected from neurogenic overactivity--a comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type A.
Compérat E; Reitz A; Delcourt A; Capron F; Denys P; Chartier-Kastler E
Eur Urol; 2006 Nov; 50(5):1058-64. PubMed ID: 16517054
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type A affects cell cycle distribution of fibroblasts derived from hypertrophic scar.
Zhibo X; Miaobo Z
J Plast Reconstr Aesthet Surg; 2008 Sep; 61(9):1128-9. PubMed ID: 18555763
[No Abstract] [Full Text] [Related]
14. Botulinum toxin A for the treatment of delayed gastric emptying.
Friedenberg FK; Palit A; Parkman HP; Hanlon A; Nelson DB
Am J Gastroenterol; 2008 Feb; 103(2):416-23. PubMed ID: 18070232
[TBL] [Abstract][Full Text] [Related]
15. Effect of fresh and stored botulinum toxin a on muscle and nerve ultrastructure: an electron microscopic study.
Elmas C; Ayhan S; Tuncer S; Erdogan D; Calguner E; Basterzï Y; Gozil R; Bahcelioglu M
Ann Plast Surg; 2007 Sep; 59(3):316-22. PubMed ID: 17721223
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical investigations of the influence of botulinum toxin A on the immunoreactivity of nNOS in the parotid gland of the rat.
Ellies M; Schütz S; Quondamatteo F; Laskawi R
J Oral Maxillofac Surg; 2006 Mar; 64(3):397-401. PubMed ID: 16487800
[TBL] [Abstract][Full Text] [Related]
17. Effects of botulinum toxin A on functional outcome during distraction osteogenesis.
Olabisi R; Best TM; Vanderby R; Petr S; Noonan KJ
J Orthop Res; 2007 May; 25(5):656-64. PubMed ID: 17262822
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia.
Antunes AA; Srougi M; Coelho RF; de Campos Freire G
Nat Clin Pract Urol; 2007 Mar; 4(3):155-60. PubMed ID: 17347660
[TBL] [Abstract][Full Text] [Related]
19. The antinociceptive effects of botulinum toxin therapy for anal fissure are unproven.
Jones OM
Dis Colon Rectum; 2007 May; 50(5):682-3; author reply 683. PubMed ID: 17294317
[No Abstract] [Full Text] [Related]
20. Comparison of type a botulinum toxin products in clinical use.
Pickett A; Caird D
J Clin Pharm Ther; 2008 Jun; 33(3):327-8. PubMed ID: 18452421
[No Abstract] [Full Text] [Related]
[Next] [New Search]
